Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational Study

Active, not recruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

June 30, 2025

Conditions
Liver TransplantationCarbapenem-Resistant Enterobacteriaceae Colonization
Interventions
OTHER

Application of a prognostic score

The CRECOOLT score, for the prospective cohort, will be systematically calculated once week, or at the occurrence of complications, until 60 days after OLT. The therapeutic management of all patients, during both retrospective and prospective periods, will be established by the attending physicians according with routine practice and not dictated by study protocol.

Trial Locations (6)

Unknown

Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

Università degli Studi di Padova - Unit Multivisceral Transplant Unit, Padua

Irccs Ismett, Palermo

ASST-Sette Laghi Università degli Studi dell'Insubria, Varese

Università degli Studi di Verona - Gastroenterologia, Verona

Hospital General Universitario Gregorio Maranon, Madrid

All Listed Sponsors
collaborator

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

OTHER

collaborator

ASST-Sette Laghi Università degli Studi dell'Insubria Varese

UNKNOWN

collaborator

Università degli Studi di Padova Unit Multivisceral Transplant Unit Padova

UNKNOWN

collaborator

Università degli Studi di Verona - Gastroenterologia Verona

UNKNOWN

collaborator

Hospital General Universitario Gregorio Marañon

OTHER

collaborator

Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo

UNKNOWN

lead

University of Bologna

OTHER